pantoprazole has been researched along with Laryngopharyngeal Reflux in 16 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Laryngopharyngeal Reflux: Back flow of gastric contents to the LARYNGOPHARYNX where it comes in contact with tissues of the upper aerodigestive tract. Laryngopharyngeal reflux is an extraesophageal manifestation of GASTROESOPHAGEAL REFLUX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the sensitivity and specificity of intensive empirical treatment with pantoprazole in diagnosing laryngopharyngeal reflux in adults." | 7.77 | Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux. ( Marina, MB; Masaany, M; Sani, A; Sharifa Ezat, WP, 2011) |
| " The aim of the present study was to assess the prevalence of heartburn and associated sleep complaints and the response to standard medical therapy with pantoprazole in primary and secondary care esophagitis patients in Belgium." | 7.77 | Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis. ( Imschoot, J; Kindt, S; Tack, J, 2011) |
| "From September 2013 to January 2018, patients with laryngopharyngeal reflux (LPR) disease were recruited and treated with pantoprazole, diet, and behavioral changes for 3 months." | 4.02 | Are the Acoustic Measurements Reliable in the Assessment of Voice Quality? A Methodological Prospective Study. ( Blecic, S; Delvaux, V; Finck, C; Harmegnies, B; Huet, K; Lechien, JR; Piccaluga, M; Saussez, S, 2021) |
| "To determine the sensitivity and specificity of intensive empirical treatment with pantoprazole in diagnosing laryngopharyngeal reflux in adults." | 3.77 | Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux. ( Marina, MB; Masaany, M; Sani, A; Sharifa Ezat, WP, 2011) |
| " The aim of the present study was to assess the prevalence of heartburn and associated sleep complaints and the response to standard medical therapy with pantoprazole in primary and secondary care esophagitis patients in Belgium." | 3.77 | Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis. ( Imschoot, J; Kindt, S; Tack, J, 2011) |
| "Laryngopharyngeal reflux is a prevalent, not well-understood disease affecting a high proportion of patients who seek laryngology consultation." | 1.43 | Impact of laryngopharyngeal reflux on subjective and objective voice assessments: a prospective study. ( Delvaux, V; Fourneau, AF; Harmegnies, B; Huet, K; Khalife, M; Lechien, JR; Piccaluga, M; Saussez, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Lechien, JR | 11 |
| Huet, K | 11 |
| Finck, C | 9 |
| Blecic, S | 1 |
| Delvaux, V | 9 |
| Piccaluga, M | 8 |
| Saussez, S | 11 |
| Harmegnies, B | 11 |
| Khalife, M | 10 |
| Fourneau, AF | 8 |
| Picalugga, M | 1 |
| De Marrez, LG | 1 |
| Nennstiel, S | 1 |
| Andrea, M | 1 |
| Abdelhafez, M | 1 |
| Haller, B | 1 |
| Schmid, RM | 1 |
| Bajbouj, M | 1 |
| Becker, V | 1 |
| Masaany, M | 1 |
| Marina, MB | 1 |
| Sharifa Ezat, WP | 1 |
| Sani, A | 1 |
| Kindt, S | 1 |
| Imschoot, J | 1 |
| Tack, J | 1 |
| Habermann, W | 1 |
| Schmid, C | 1 |
| Neumann, K | 1 |
| Devaney, T | 1 |
| Hammer, HF | 1 |
| Vailati, C | 1 |
| Mazzoleni, G | 1 |
| Bondi, S | 1 |
| Bussi, M | 1 |
| Testoni, PA | 1 |
| Passaretti, S | 1 |
3 trials available for pantoprazole and Laryngopharyngeal Reflux
| Article | Year |
|---|---|
Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease.
Topics: Diet; Female; Humans; Laryngopharyngeal Reflux; Male; Middle Aged; Pantoprazole; Patient Compliance; | 2018 |
Validity and Reliability of a French Version of Reflux Symptom Index.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; France; Humans; Laryngophar | 2017 |
Oropharyngeal pH monitoring for laryngopharyngeal reflux: is it a reliable test before therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Esophageal pH Monitoring; Female; Humans; Laryngopha | 2013 |
13 other studies available for pantoprazole and Laryngopharyngeal Reflux
| Article | Year |
|---|---|
Are the Acoustic Measurements Reliable in the Assessment of Voice Quality? A Methodological Prospective Study.
Topics: Acoustics; Humans; Laryngopharyngeal Reflux; Pantoprazole; Prospective Studies; Voice Quality | 2021 |
Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Esophageal pH Monitoring; Esophag | 2017 |
Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Case-Control Studies; Dysphonia; Female; Hoarseness; | 2018 |
Impact of Laryngopharyngeal Reflux on Subjective, Aerodynamic, and Acoustic Voice Assessments of Responder and Nonresponder Patients.
Topics: Diet; Dysphonia; Female; Humans; Laryngopharyngeal Reflux; Male; Middle Aged; Pantoprazole; Phonatio | 2019 |
Voice Quality as Therapeutic Outcome in Laryngopharyngeal Reflux Disease: A Prospective Cohort Study.
Topics: Acoustics; Diet, Healthy; Female; Humans; Laryngopharyngeal Reflux; Male; Middle Aged; Pantoprazole; | 2020 |
Alkaline, protein, low-fat and low-acid diet in laryngopharyngeal reflux disease: Our experience on 65 patients.
Topics: Acid-Base Equilibrium; Belgium; Diet, Fat-Restricted; Diet, Protein-Restricted; Esophageal pH Monito | 2019 |
Clinical and Acoustical Voice Quality Evolutions Throughout Empirical Treatment for Laryngopharyngeal Reflux Disease According to Gender: A Preliminary Study.
Topics: Acoustics; Female; Hoarseness; Humans; Laryngopharyngeal Reflux; Male; Pantoprazole; Phonation; Prot | 2020 |
Phonetic Approaches of Laryngopharyngeal Reflux Disease: A Prospective Study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acoustics; Adult; Aged; Combined Modality Therapy; Female; | 2017 |
pH/multichannel impedance monitoring in patients with laryngo-pharyngeal reflux symptoms - Prediction of therapy response in long-term follow-up.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Esophageal pH Monitoring; Female; Humans; Lary | 2016 |
Impact of laryngopharyngeal reflux on subjective and objective voice assessments: a prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Female; Humans; Laryngopharyngeal Reflux; Lary | 2016 |
Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Body Mass Index; Double-Blind Method; En | 2011 |
Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Alcoholism; Anorexia; Anti-Inflammatory Agents | 2011 |
Reflux symptom index and reflux finding score in otolaryngologic practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Austria; Female | 2012 |